Medical devices, healthcare technology and the business of care
510(k) clearance · K252984

Perin Health System (PHD80060-2)

Perin Health Devices, LLC · Decision date Jan 22, 2026

FDA DECISIONK252984

What did the FDA decide?

FDA records K252984 as a 510(k) premarket notification, with a decision dated Jan 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Jan 22, 2026

FDA source record

Regulatory record facts

Identifier
K252984
Regulatory pathway
510(k) premarket notification
Product code
DRG
Decision code
SESE
Decision date
Jan 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Transmitters And Receivers, Physiological Signal, Radiofrequency.

Product code
DRG
FDA device class
2

FDA decision timeline

  1. K252984 received

    Application receipt date recorded by FDA.

  2. K252984 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DRG

Product / regulatory recordCompanyPathwayDecision dateSource
Lifesignals, Inc.510(k) clearanceJul 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Perin Health Devices, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Oklahoma City, OK

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records